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Volume 52, Number 6 Abstracts 1739Table. Univariant/multivariant analysis of preoperative
thrombus load and aortic side branches and endoleak
Univariate Early type II endoleak Late type II endoleak
Increment OR 95% CI
P
value OR 95% CI
P
value
Neck thickness 5 mm 0.863 0.459-
1.624
.64850.751 0.382-
1.476
.406
Maximum thickness
zone B
5 mm 0.791 0.657-
0.954
.01420.934 0.786-
1.111
.4425
% Thrombus-lined
aneurysm wall
circumference
10% 0.88 0.781-
0.992
.03610.884 0.782-
0.999
.0476
Maximum thickness
zone A
5 mm 0.776 0.624-
0.965
.02270.922 0.751-
1.132
.4358
Maximum thickness
zone C
5 mm 0.824 0.683-
0.994
.043 0.908 0756-
1.091
.303
Aortic side
branches with
patent IMA
1 0.993 0.844-
1.168
.93191.392 1.136-
1.706
.0014
Size of AAA 1cm 0.798 0.530-
1.203
.28160.581 0.361-
0.933
.0248
Multivariate Early type II endoleak Late type II endoleak
Increment OR 95% CI
P
value OR 95% CI
P
value
Neck thickness 5 mm
Maximum thickness
zone B
5 mm 0.843 0.573-
1.241
.3873
% thrombus lined
aneurysm wall
circumference
10% 0.926 0.795-
1.078
.32080.947 0.827-
1.085
.4333
Maximum thickness
zone A
5 mm 0.882 0.512-
1.52
.6513
Maximum thickness
zone C
5 mm 1.16 0.754-
1.785
.5
Aortic side
branches with
patent IMA
1 1.338 1.077-
1.664
.0087
Size of AAA 1 cm 0.71 0.428-
1.178
.1848Endovascular Treatment of Acute and Chronic Aortic Pathology in
Patients With Marfan’s Syndrome
Alyson L. Waterman, Robert J. Feezor, Peter R. Nelson, W. Anthony Lee,
Philip J. Hess, Tomas D. Martin, Thomas S. Huber, Adam W. Beck,
University of Florida, Gainesville, Fla
Background: Aortic dissection and rupture is the main cause of
mortality in patients with Marfan’s syndrome. Although the ascending
aorta must still be managed using open operative techniques, endovas-
cular repair is now available for management of the descending thoracic
and abdominal aorta (TEVAR/EVAR). The short- and long-term benefit
of endovascular repair in Marfan’s patients is unproven. We have sought
to examine our outcomes after endovascular repair in this population.
Methods: Using a database kept at the University of Florida, a retro-
spective review was preformed of all patients with a diagnosis of Marfan’s
syndrome who have undergone TEVAR/EVAR for acute and chronic aortic
pathology. The primary endpoints were in-hospital and overall mortality and
need for additional surgical interventions.
Results: Between January 2004 and June 2010, 16 patients were
identified as having undergone 19 TEVAR/EVAR procedures (one EVAR,
15 TEVAR, and three combined TEVAR/EVAR). The median patient age
at operation was 52 years (range 26-78). Fifteen of 16 patients underwent
surgery of the ascending aorta or arch at a time interval ranging from 17 years
to 1 week prior. Thirteen patients underwent elective TEVAR/EVAR for
chronic dissection and/or aneurysmal dilation of the descending aorta. The
remaining three underwent emergent procedures (two for acute dissection/
malperfusion and one for anastomotic disruption early after open repair).
Three patients underwent secondary TEVARs 6-28 months after their index
TEVAR. Among the 18 TEVARs, 4 required adjunctive endovascular
procedures (1 subclavian artery embolization, 1 vertebral artery stent, 1 renal
artery stent, 1 celiac and SMA stent); all EVARs required complex adjunctive
endovascular procedures involving visceral arteries. During a median fol-
low-up of 32.5 months (range 0-75 months), seven patients (44%) required
subsequent surgical procedures including the three who underwent second
TEVARs (Table). Five patients died during the follow-up period, including
two in the perioperative period (one of whom was the patient who under-
went emergent TEVAR for anastomotic disruption, and one was a patient
who required multi-visceral revascularization in conjunction with his second
TEVAR). Two deaths occurred after discharge (respiratory failure and
cardiac arrest at 3 and 4 months postoperatively). One death was due to
advanced age 6.2 years after EVAR (age 84 at death). In longer-term
follow-up, 11/16 patients are alive and stable (69% overall survival) includ-
ing two who required TEVAR for acute malperfusion, one who required
stentgraft explantation, and four who required other subsequent surgical
procedures (Table).
Conclusion: Aortic disease associated with Marfan’s syndrome is a
complex clinical problem, and endovascular therapy provides a useful ad-
junct to open surgical treatment in some patients. In a select group of
patients, endovascular therapy can be a definitive therapy, however close
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December 20101740 Abstractspostoperative follow-up is important as many patients require further
interventions.
Table.
Age Indication Procedure
Months
follow-up
Subsequent
intervention Alive
40.2 Aneurysm TEVAR 0.1 None Yes
38.2 Operative Anastomotic
disruption
TEVAR 1.0 None No
28.0 Aneurysm TEVAR 1.1 None Yes
26.5 Aneurysm TEVAR 3.3 Emergent open repair
for rupture of false
lumen
No
28.6 Acute dissection with
LE malperfusion
TEVAR 3.5 None Yes
32.9 Aneurysm TEVAR 3.8 None No
52.8 Aneurysm TEVAR 4.6 Open arch revision
for retrograde
dissection
Yes
57.4 Aneurysm TEVAR 8.2 Open repair with
stent explantation
(type I endoleak)
Yes
37.0 Acute dissection with
LE malperfusion
TEVAR 8.4 TEVAR for new distal
TAA
Yes
60.9 Pseudoaneurysm TEVAR 10.4 None Yes
60.8 Aneurysm TEVAR 19.8 None Yes
46.1 Chronic retrograde
dissection
TEVAR/
EVAR
21.5 Open repair with
stent explantation
(type I endoleak);
Secondary
TEVAR/EVAR
No
65.0 Aneurysm TEVAR 24.7 Open repair Yes
35.3 Aneurysm TEVAR 27.1 None Yes
54.0 Aneurysm TEVAR/
EVAR
37.3 Multiple open and
endovascular
revisions;
Secondary TEVAR
with multi-visceral
chimney
Yes
78.0 Aneurysm EVAR 75.1 None No
Protocol Implementation of Selective PostOperative Lumbar Spinal
Drainage after Thoracic Aortic Endograft
Charles J. Keith, Marc A. Passman, Mark A. Patterson, Steve M. Taylor,
WilliamD. Jordan, Jr, University of Alabama at Birmingham, Birmingham, Ala
Background: Spinal cord ischemia (SCI) remains a substantial concern
in patients undergoing endovascular repair involving thoracic aorta
(TEVAR). Although perioperative lumbar spinal drainage has been widely
practiced for open repair, there is no consensus treatment protocol using
lumbar drainage for SCI associated with TEVAR. This study analyzes the
efficacy of an institutional protocol using selective lumbar drain reserved for
patients experiencing SCI following TEVAR.
Methods: A prospectively maintained registry was reviewed to identify
all patients who underwent TEVAR from January 2000 through June 2010.
Preoperative characteristics (thoracic aortic pathology, existence of infrare-
nal aortic pathology, and urgency of repair), intraoperative details (extent of
aortic coverage, patency of the left subclavian artery, presence of an en-
doleak, preoperative and postoperative mean arterial pressures), and out-
comes (neurological deficit, postoperative hospital days, and mortality at
30-day and 1-year) were determined. Patients developing symptoms of SCI
in the postoperative setting were compared to those without neurologic
symptoms. Our institutional preference for selective lumbar drainage re-
served for those developing SCI after TEVAR was formalized into a pro-
spective protocol in 2007. SCI patients who received selective lumbar
drainage were grouped based on resolution of neurologic function (full,
partial, and no resolution), and risk factors and outcomes of these sub-
groups were analyzed statistically with 2, t test, and logistic regression.
Results: Two hundred seventy-eight TEVAR procedures were per-
formed on 251 patients. Five patients accounting for five procedures expe-
rienced SCI preoperatively and were excluded from analysis. Of the remain-
ing 273 procedures in 246 patients, 17 (6.2%) developed SCI within the
30-day postoperative period. Six patients received lumbar drain preopera-
tively as exception to protocol due to increased concern for risk of SCI, and
one from this group developed SCI postoperatively. Risk factors for SCI
reaching statistical significance included length of aortic coverage (P .029)
and existence of infrarenal aortic pathology (P .03). Left subclavian artery
stent graft coverage was required in 29.1% (n  80) and was not associated
with SCI (P  .674). Association of SCI with prior stroke (P  .051) and
hospital length of stay (P .057) reached marginal significance. In patients
with SCI, increased all cause mortality was observed at 1 year (52.3% vs
21.5%; P  .006). Eleven of the 17 SCI patients received selective postop-
erative lumbar drains, and were categorized based on resolution of symp-toms into full resolution (n  4; 36.4%), partial resolution (n  4; 36.4%),
and no resolution (n  3; 27.3%). No patient characteristics or risk factors
mentioned above reached significance in comparison of symptom resolution
across lumbar drained patients and non-drained patients. Six of seven
patients without complete resolution of SCI died within the first year after
surgery, while all four of the complete responders survived (P  .06).
Conclusion: A protocol utilizing selective postoperative lumbar spinal
drainage can be used safely for patients developing SCI after TEVAR with
acceptably low postoperative SCI rates causing permanent neurologic defi-
cit, although overall outcome of patients experiencing SCI after TEVAR is
diminished relative to non-SCI patients.
Emergency Procedures on the Descending Thoracic Aorta in the En-
dovascular Era
Marc E. Mitchell, Fred W. Rushton Jr, A. Bradley Boland, Taylor C. Byrd,
Zachary K. Baldwin, University of Mississippi, Jackson, Miss
Background: Thoracic endovascular aortic repair (TEVAR), initially
developed for the treatment of degenerative aneurysms of the descending
thoracic aorta, has been applied to the entire spectrum of descending
thoracic aortic pathology in both the elective and emergent settings. This
single center study evaluates the effectiveness of TEVAR for the treatment of
acute surgical emergencies involving the descending thoracic aorta, includ-
ing traumatic aortic disruption (TAD), ruptured descending thoracic aneu-
rysm (RDTA), and acute complicated type B dissection (cTBD).
Methods: A retrospective review of the medical records of all patients
undergoing emergent TEVAR at a tertiary care medical center with a level 1
trauma center between August 2007 and August 2010 was undertaken.
Study endpoints included: 30-day survival, complications, type of device
used for the repair and technical aspects of the procedure.
Results: A total of 42 patients (62%male) with an average age of 50 years
underwent emergent TEVAR during the study period. The technical success
rate was 100%, with no patient requiring emergent open surgery for conditions
involving the descending thoracic aorta at our institution during the study
period. The majority (71%) of the repairs were accomplished using commer-
cially available thoracic stent grafts. Abdominal stent graft components were
used in 40% of patients undergoing repair of TAD. Twenty patients (48%)
required coverage of the left subclavian artery, two of whom subsequently
required subclavian artery revascularization. Procedure related complications
included: 1 stroke, 1 spinal cord ischemia, 1 unintentional coverage of the left
carotid artery, 1 episode of acute renal failure and 2 access site injuries. Two
patients undergoing repair of TAD had collapse of the stent graft in the early
postoperative period. Both were successfully treated by placement of an addi-
tional stent graft. Sevenpatients (17%)diedwithin30days of surgery.Threehad
successfully undergone repair of a TAD and died of associated injuries.
Type of aortic
pathology
Mean age
(range)
Type of
device
Subclavian artery
coverage 30-day survival
TAD 43 (16-77) Thoracic-18 15 of 30 (50%) 27 of 30 (90%)
N  30 Abdominal-
12
RDTA 68 (54-87) Thoracic - 7 3 of 7 (43%) 4 of 7 (57%)
N  7
cTBD 67 (50-77) Thoracic-4 2 of 4 (50%) 3 of 4 (75%)
N  4
Distal aortic
tear
42 Thoracic-1 0 1/1 (100%)
N  1
Total 50 (16-87) Thoracic-30 20 of 42 (48%) 35 of 42 (83%)
N  42 Abdominal-
12
Conclusions: Emergent TEVAR has become the treatment of choice
for acute surgical emergencies involving the descending thoracic aorta.
Short-term results compare favorably to published historic results for emer-
gent open surgical procedures on the descending thoracic aorta. Survival is
highest in patients undergoing repair of TAD. Using current stent graft
technology, nearly all emergent conditions of the descending thoracic aorta
can be successfully treated with TEVAR. Subclavian artery coverage is
required in half of patients, and can be performed safely. A minority will
subsequently require subclavian artery revascularization.
Volumetric Analysis of the Thoracic Aorta in Type B Dissection
Treated with TEVAR
Gregory A. Stanley, Martyn Knowles, Erin H.Murphy, Mihaila Ilves, Carlos
H. Timaran, Michael Jessen, J. Michael Dimaio, Frank R. Arko, UT South-
western, Dallas, Tex
Background: Type B aortic dissections are being successfully treated
by thoracic endovascular aortic repair (TEVAR). Persistent postoperative
false lumen filling has been associated with aneurysmal dilatation of the
